• Dr. Knudson and the Two-Hit Theory

    by  • April 30, 2013

    Fox Chase researcher Alfred G. Knudson Jr., MD, PhD, was recently inaugurated into the first class of the Fellows of the AACR Academy at the AACR Annual Meeting 2013, held in Washington, D.C. The inaugural group of fellows of the academy consists of 106 individuals, symbolizing the age of the organization upon establishment of...

    Read more →

    Minimally Invasive Esophagectomy: A Better Surgical Option for Patients with Esophageal Cancer

    by  • April 26, 2013

    In 2012, the American Cancer Society estimated the annual number of new esophageal cancers at 17,460. Surgical resection with radical lymph node dissection, usually performed after a patient receives either preoperative chemotherapy or chemoradiation, is regarded as the only curative option for resectable esophageal cancer. Surgical removal of the esophagus and reconstruction of the...

    Read more →

    What is Genetic Testing?

    by  • April 25, 2013

    Genetic testing is a blood test that looks for changes, also called alterations or mutations, in genes. These changes cause disease or place someone at higher risk for getting a certain disease, such as cancer. Sometimes these gene changes can be passed from parent to child. Genetic testing, as part of cancer risk assessment,...

    Read more →

    Fatigue and Cancer Treatment

    by  • April 24, 2013

    Fatigue, or feeling tired, is a common side effect of cancer treatment. But patients don’t have to lie down when it comes to dealing with it. Fox Chase has a program that teaches patients how to manage fatigue using a multi-faceted approach. “Fatigue is one of the primary complaints of cancer patients, no matter...

    Read more →

    Fox Chase Researchers at the AACR Meeting

    by  • April 23, 2013

    At the annual meeting of the American Association for Cancer Research (AACR), April 6-10, 2013, in Washington, DC, Fox Chase researchers presented a series of papers that covered a range of oncology treatments, from breast cancer to a promising drug can help prevent head and neck cancers. In addition, esteemed Fox Chase Cancer Center...

    Read more →

    Patients’ Genes Provide a Blueprint for Hope in Cancer Treatment

    by  • April 22, 2013

    A article in yesterday’s  New York Times (“Cancer Centers Racing to Map Patients’ Genes” April 21, 2013) discusses the emerging importance of gene mapping in determining precise medical treatment. Fox Chase Cancer Center has been pursuing this course of treatment for oncology patients, plotting a genetic “blueprint” for targeting treatment in advanced cancers. The...

    Read more →

    Understanding Choices for Urinary Diversion at the time of Bladder Removal Surgery

    by  • April 6, 2013

    Patients who are faced with bladder removal (cystectomy) are presented with a number of challenges, not the least of which is understanding the type of urinary diversion that is best for them. There are 3 basic categories of modern urinary diversions: (1) incontinent bowel conduit (e.g. ileal conduit) (2) continent cutaneous stomal reservoire (e.g....

    Read more →

    Objectifying Surgical Decision Making for Renal Masses

    by  • April 3, 2013

    In the absence of level I evidence, physician treatment recommendations are subject not only to the objective (interpretations of the cohort literature and practice guidelines), but also the subjective (training patterns, comfort levels, biases and individual experiences).  Such is the case for management of the incidental renal mass where multiple therapeutic options exist.  This...

    Read more →